Incretin Market Competitive Landscape and Emerging Metabolic Disease Treatment Opportunities
The Incretin Market is expanding as interest in hormone-based treatments for type 2 diabetes and obesity continues to increase. Incretins are metabolic hormones, primarily glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), that help regulate blood glucose levels by stimulating insulin secretion in response to food intake. These hormones also influence...
0 Commentarii 0 Distribuiri 15 Views 0 previzualizare
social art-inpa https://social.art-inpa.com